Literature DB >> 21327454

Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.

Jong-Lyel Roh1, Jin-Man Kim, Chan Il Park.   

Abstract

BACKGROUND: Although subclinical cervical lymph node (LN) metastases in papillary thyroid carcinoma (PTC) are common, the efficacy of prophylactic central LN dissection (CLND) is unclear. Few prospective studies have assessed the relationships between complete pathologic information regarding tumors and metastatic nodes in the central compartment. We therefore investigated the pattern and predictive indicators of central LN metastasis, morbidity, and recurrence in patients who underwent total thyroidectomy and prophylactic CLND for unilateral PTC and clinically node-negative neck (cN0) disease.
METHODS: This prospective study involved 184 patients with previously untreated unilateral PTC and cN0 who underwent total thyroidectomy and bilateral CLND. Nodal samples were divided into the prelaryngeal/pretracheal and ipsilateral and contralateral paratracheal regions, with each assessed for clinicopathologic predictors of central metastases. Postoperative morbidity and recurrence were assessed.
RESULTS: Rates of metastasis to ipsilateral and contralateral central compartments were 42.9 and 9.8%, respectively. Multivariate analysis showed that tumor size >1 cm and extrathyroidal extension were independent predictors of ipsilateral metastasis, and ipsilateral metastases independently predicted contralateral metastases (P < 0.05 each). Permanent hypoparathyroidism and incidental recurrent nerve paralysis were found in 1.6 and 0% of patients, respectively. After a mean follow-up of 46 months, none of these patients had recurrence in the central compartment.
CONCLUSIONS: Subclinical metastases are highly prevalent in the ipsilateral central neck of patients with PTC >1 cm. Contralateral central metastases, although uncommon, are associated with ipsilateral central metastases. These findings may guide the necessity and extent of prophylactic bilateral or unilateral CLND.

Entities:  

Mesh:

Year:  2011        PMID: 21327454     DOI: 10.1245/s10434-011-1600-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  64 in total

1.  Quantification of lymph nodes in the central compartment of the neck: a cadaveric study.

Authors:  Enyinnaya Ofo; Selvam Thavaraj; Daron Cope; James Barr; Karan Kapoor; Jean-Pierre Jeannon; Richard Oakley; Claire Lock; Edward Odell; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-20       Impact factor: 2.503

2.  Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study.

Authors:  Qiang Chen; Xiu-He Zou; Tao Wei; Qiu-Shi Huang; Ying-He Sun; Jing-Qiang Zhu
Journal:  Gland Surg       Date:  2015-08

3.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

4.  A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis.

Authors:  Zhong Ying Rui; Yang Liu; Wei Zheng; Xuan Wang; Zhao Wei Meng; Jian Tan; Ning Li; Qiang Jia
Journal:  Clin Exp Med       Date:  2021-01-01       Impact factor: 3.984

5.  Clinical and sonographic assessment of cervical lymph node metastasis in papillary thyroid carcinoma.

Authors:  Qi Wu; Yi-Min Zhang; Si Sun; Juan-Juan Li; Juan Wu; Xiang Li; Shan Zhu; Wen Wei; Sheng-Rong Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

6.  Pathologic features of metastatic lymph nodes identified from prophylactic central neck dissection in patients with papillary thyroid carcinoma.

Authors:  Hyoung Shin Lee; Chanwoo Park; Sung Won Kim; Woong Jae Noh; Soo Jin Lim; Bong Kwon Chun; Beom Su Kim; Jong Chul Hong; Kang Dae Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-12       Impact factor: 2.503

7.  Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.

Authors:  Hwan Seo Lee; Jong-Lyel Roh; Gyungyup Gong; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

Review 8.  Advances in surgical therapy for thyroid cancer.

Authors:  Haggi Mazeh; Herbert Chen
Journal:  Nat Rev Endocrinol       Date:  2011-08-23       Impact factor: 43.330

9.  Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?

Authors:  Brian Hung-Hin Lang; Cathy Po-Ching Ng; Kin Bun Au; Kai Pun Wong; Kandy K C Wong; Koon Yat Wan
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

Review 10.  The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma.

Authors:  Anthony R Glover; Justin S Gundara; Olov Norlén; James C Lee; Stan B Sidhu
Journal:  Gland Surg       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.